Related Experiment Video

Updated: May 30, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

AC13, a C-terminal fragment of apolipoprotein A-I, is a candidate biomarker for microscopic polyangiitis

Yukiko Takakuwa1, Manae S Kurokawa, Seido Ooka

  • 1St. Marianna University School of Medicine, Kawasaki, Japan.

Arthritis and Rheumatism
|July 28, 2011
PubMed
Abstract

Insights

Researchers identified AC13, a peptide fragment of apolipoprotein A-I, as a potential biomarker for microscopic polyangiitis (MPA). This finding may aid in monitoring MPA disease activity and understanding its inflammatory mechanisms.

Area of Science:

  • Immunology
  • Biochemistry
  • Vascular Biology

Background:

  • Microscopic polyangiitis (MPA) is a systemic necrotizing vasculitis with an unknown cause.
  • Identifying reliable biomarkers is crucial for diagnosing and managing MPA.

Purpose of the Study:

  • To analyze the serum peptide profile of MPA patients to discover a potential disease biomarker.
  • To investigate the functional role of identified peptides in vascular inflammation.

Main Methods:

  • Serum peptides from MPA patients and controls (other vasculitides, SLE, rheumatoid arthritis, healthy subjects) were analyzed using mass spectrometry.
  • Peptide function was assessed on human microvascular endothelial cells (HMVECs) via ELISA and real-time PCR.

Main Results:

  • A specific peptide, AC13 (13 C-terminal residues of apolipoprotein A-I), showed significantly higher ion intensity in MPA patients compared to controls.
  • AC13 levels decreased with MPA treatment and were associated with lower apolipoprotein A-I and HDL cholesterol.
  • AC13 stimulation of HMVECs increased the secretion of pro-inflammatory cytokines IL-6 and IL-8.

Conclusions:

  • AC13 is a promising candidate biomarker for MPA, potentially useful for monitoring disease activity.
  • AC13 may contribute to vascular inflammation by up-regulating pro-inflammatory cytokines.

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial Disease08:38

Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial Disease

Published on: August 26, 2017

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...